Lars Husmann1, Martin W Huellner2, Bruno Ledergerber3, Alexia Anagnostopoulos3, Paul Stolzmann2, Bert-Ram Sah2,4,5, Irene A Burger2, Zoran Rancic6, Barbara Hasse3. 1. Department of Nuclear Medicine, University Hospital of Zurich / University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. lars.husmann@usz.ch. 2. Department of Nuclear Medicine, University Hospital of Zurich / University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. 3. Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich / University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. 4. Institute of Diagnostic and Interventional Radiology, Department Medical Radiology, University Hospital of Zurich / University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. 5. Department of Cancer Imaging, King's College London, London, UK. 6. Clinic for Cardiovascular Surgery, University Hospital of Zurich / University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
Abstract
BACKGROUND: To evaluate the diagnostic accuracy of positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (PET/CT), contrast-enhanced CT (CE-CT), and a combined imaging approach (CE-PET/CT) in patients with suspected vascular graft infection (VGI). METHODS: PET/CT and CE-CT were performed prospectively in 23 patients with suspected VGI. Diagnostic accuracy for PET/CT was assessed by using previously suggested cut-off points for maximum standardized uptake values (SUVmax) measured in the vicinity of the graft. Using a new 4-point scale for visual grading, two readers independently assessed the diagnostic accuracy for CE-CT and combined CE-PET/CT. Microbiological culture, obtained after open biopsy or graft explantation, and clinical follow-up of the patients served as the standard of reference. RESULTS: Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of PET/CT for the diagnosis of VGI was 100%, 50%, 100%, 72.2%, and 78.3%, using the most favorable SUVmax cut-off ≥ 4.9. Respective values for CE-CT were 100%, 50%, 100%, 72.2%, and 78.3% for reader 1, and 92.3%, 80%, 88.9%, 85.7%, and 86.9% for reader 2; while respective values for combined CE-PET/CT were 100%, 70%, 100%, 81.3%, and 86.9% for reader 1, and 100%, 80%, 100%, 86.7%, and 91.3% for reader 2. Additionally, imaging provided a conclusive clinical diagnosis in patients without graft infection (i.e., other sites of infection): five of ten patients with CE-CT, six of ten patients with PET/CT, and seven of ten patients with combined CE-PET/CT. CONCLUSION: The diagnostic accuracy of combined CE-PET/CT in patients with suspected VGI is very high. The combination of the high sensitivity of PET/CT in detecting metabolically active foci in infection, and the high specificity of CE-CT in detecting anatomic alterations, appears to be the reason why combined imaging outperforms stand-alone imaging in diagnosing VGI and may be supportive in future decision-making of difficult cases of suspected VGI. Clinical Trials.gov Identifier: NCT01821664.
BACKGROUND: To evaluate the diagnostic accuracy of positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (PET/CT), contrast-enhanced CT (CE-CT), and a combined imaging approach (CE-PET/CT) in patients with suspected vascular graft infection (VGI). METHODS: PET/CT and CE-CT were performed prospectively in 23 patients with suspected VGI. Diagnostic accuracy for PET/CT was assessed by using previously suggested cut-off points for maximum standardized uptake values (SUVmax) measured in the vicinity of the graft. Using a new 4-point scale for visual grading, two readers independently assessed the diagnostic accuracy for CE-CT and combined CE-PET/CT. Microbiological culture, obtained after open biopsy or graft explantation, and clinical follow-up of the patients served as the standard of reference. RESULTS: Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of PET/CT for the diagnosis of VGI was 100%, 50%, 100%, 72.2%, and 78.3%, using the most favorable SUVmax cut-off ≥ 4.9. Respective values for CE-CT were 100%, 50%, 100%, 72.2%, and 78.3% for reader 1, and 92.3%, 80%, 88.9%, 85.7%, and 86.9% for reader 2; while respective values for combined CE-PET/CT were 100%, 70%, 100%, 81.3%, and 86.9% for reader 1, and 100%, 80%, 100%, 86.7%, and 91.3% for reader 2. Additionally, imaging provided a conclusive clinical diagnosis in patients without graft infection (i.e., other sites of infection): five of ten patients with CE-CT, six of ten patients with PET/CT, and seven of ten patients with combined CE-PET/CT. CONCLUSION: The diagnostic accuracy of combined CE-PET/CT in patients with suspected VGI is very high. The combination of the high sensitivity of PET/CT in detecting metabolically active foci in infection, and the high specificity of CE-CT in detecting anatomic alterations, appears to be the reason why combined imaging outperforms stand-alone imaging in diagnosing VGI and may be supportive in future decision-making of difficult cases of suspected VGI. Clinical Trials.gov Identifier: NCT01821664.
Authors: Janneke L M Bruggink; Riemer H J A Slart; Jillis A Pol; Michel M P J Reijnen; Clark J Zeebregts Journal: Semin Vasc Surg Date: 2011-12 Impact factor: 1.000
Authors: J L M Bruggink; A W J M Glaudemans; B R Saleem; R Meerwaldt; H Alkefaji; T R Prins; R H J A Slart; C J Zeebregts Journal: Eur J Vasc Endovasc Surg Date: 2010-06-23 Impact factor: 7.069
Authors: A C Pfannenberg; P Aschoff; K Brechtel; M Müller; M Klein; R Bares; C D Claussen; S M Eschmann Journal: Br J Radiol Date: 2007-02-28 Impact factor: 3.039
Authors: Lars Husmann; Martin W Huellner; Nadia Eberhard; Bruno Ledergerber; Marisa B Kaelin; Alexia Anagnostopoulos; Ken Kudura; Irene A Burger; Carlos-A Mestres; Zoran Rancic; Barbara Hasse Journal: Sci Rep Date: 2021-03-03 Impact factor: 4.379
Authors: Chiara Lauri; Alberto Signore; Andor W J M Glaudemans; Giorgio Treglia; Olivier Gheysens; Riemer H J A Slart; Roberto Iezzi; Niek H J Prakken; Eike Sebastian Debus; Susanne Honig; Anne Lejay; Nabil Chakfé Journal: Eur J Nucl Med Mol Imaging Date: 2022-04-04 Impact factor: 10.057
Authors: Lars Husmann; Martin W Huellner; Hannes Gruenig; Bruno Ledergerber; Michael Messerli; Carlos-A Mestres; Zoran Rancic; Barbara Hasse Journal: PLoS One Date: 2022-08-09 Impact factor: 3.752
Authors: Lars Husmann; Nadia Eberhard; Martin W Huellner; Bruno Ledergerber; Anna Mueller; Hannes Gruenig; Michael Messerli; Carlos-A Mestres; Zoran Rancic; Alexander Zimmermann; Barbara Hasse Journal: Sci Rep Date: 2021-07-02 Impact factor: 4.379